Advances in the Clinical Management of Hereditary Angioedema Standard of Care, New and Emerging Therapies, Patient-Centered Care & Shared Decision-making

Advances in the Clinical Management of Hereditary Angioedema Standard of Care, New and Emerging Therapies, Patient-Centered Care & Shared Decision-making is organized by Practice Point Communications (PPC).

Launch Date: February 16, 2021
Release Date: February 10, 2021
Expiration Date: January 31, 2022

Accreditation:
Review the slides by selecting the View Slide Kit button on the right. Claim 1 AMA, ANCC, or ACPE credit/contact hour per slide kit after completion of a brief posttest/evaluation.

Description:
The Clinical Viewpoints Hereditary Angioedema lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slides developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

The field of hereditary angioedema (HAE) has recently evolved with the advent of new and forthcoming diagnostic and treatment measures. In particular, the shift toward oral medications will most certainly improve the quality of life for HAE patients. This lecture provides an overview of current diagnostic and treatment procedures recommended by the World Allergy Organization (WAO) and the United States Hereditary Angioedema Association Medical Advisory Board (US HAEA MAB) and summarizes forthcoming new advances in the field of HAE.

Additional details will be posted as soon as information is available.